ProVise Management Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,236
| Closed | -$908K | – | 273 |
|
|
2024
Q3 | $908K | Buy |
6,236
+91
| +1% | +$13.3K | 0.07% | 157 |
|
|
2024
Q2 | $843K | Sell |
6,145
-146
| -2% | -$20K | 0.07% | 154 |
|
|
2024
Q1 | $863K | Sell |
6,291
-10
| -0.2% | -$1.37K | 0.07% | 154 |
|
|
2023
Q4 | $856K | Sell |
6,301
-21
| -0.3% | -$2.85K | 0.07% | 184 |
|
|
2023
Q3 | $773K | Sell |
6,322
-1,086
| -15% | -$133K | 0.07% | 188 |
|
|
2023
Q2 | $941K | Sell |
7,408
-4,170
| -36% | -$529K | 0.09% | 179 |
|
|
2023
Q1 | $1.5M | Sell |
11,578
-541
| -4% | -$69.9K | 0.14% | 135 |
|
|
2022
Q4 | $1.59M | Buy |
12,119
+2,296
| +23% | +$301K | 0.16% | 129 |
|
|
2022
Q3 | $1.15M | Buy |
9,823
+3,252
| +49% | +$380K | 0.13% | 144 |
|
|
2022
Q2 | $773K | Sell |
6,571
-225
| -3% | -$26.5K | 0.08% | 173 |
|
|
2022
Q1 | $886K | Sell |
6,796
-417
| -6% | -$54.4K | 0.08% | 183 |
|
|
2021
Q4 | $1.1M | Buy |
7,213
+96
| +1% | +$14.7K | 0.1% | 175 |
|
|
2021
Q3 | $1.15M | Buy |
7,117
+552
| +8% | +$89.3K | 0.11% | 157 |
|
|
2021
Q2 | $1.07M | Sell |
6,565
-366
| -5% | -$59.9K | 0.11% | 163 |
|
|
2021
Q1 | $1.04M | Buy |
6,931
+406
| +6% | +$61.2K | 0.11% | 157 |
|
|
2020
Q4 | $988K | Buy |
6,525
+428
| +7% | +$64.8K | 0.11% | 150 |
|
|
2020
Q3 | $826K | Buy |
6,097
+2,127
| +54% | +$288K | 0.11% | 155 |
|
|
2020
Q2 | $543K | Buy |
3,970
+1,131
| +40% | +$155K | 0.08% | 175 |
|
|
2020
Q1 | $306K | Buy |
+2,839
| New | +$306K | 0.05% | 214 |
|
|
2017
Q3 | – | Sell |
-6,156
| Closed | -$636K | – | 329 |
|
|
2017
Q2 | $636K | Buy |
+6,156
| New | +$636K | 0.1% | 185 |
|